Clinical trials
Bronchiectasis Adult clinical trials
Below are recruiting bronchiectasis adult clinical trials, each written for real people, not researchers. We’re tracking 21 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06931002Recruiting
Cold virus study in bronchiectasis and healthy volunteers
This study tests whether giving a common cold virus (rhinovirus) to people with bronchiectasis and healthy volunteers can trigger a lung flare-up. It aims to understand how the immune system responds and what causes exacerbations, which could lead to better treatments.
LondonAges 18–65 - NCT07135284Recruiting
Testing the LibAirty System for Bronchiectasis at Home
This trial tests the LibAirty system, a device that helps clear mucus from your lungs, in people with bronchiectasis. Participants use the device at home to see how well it works in daily life.
Birmingham, AlabamaAges 21 years+ - NCT07708116RecruitingPhase 1
First human trial of CTX-187 for healthy people and those with chronic infection
This trial tests a new drug called CTX-187 in two groups: healthy volunteers (Parts A and B) and people with chronic lung infection from bronchiectasis (Part C). It helps find the right dose and checks safety.
GroningenAges 18–65 - NCT06625944Recruiting
How viral infections affect lung disease
This study looks at how viral infections impact people with chronic lung conditions like COPD or bronchiectasis. It aims to understand symptoms and triggers better, which could help improve future treatments.
LondonAges 18 years+ - NCT06443658RecruitingPhase 3
The ELTGOL breathing technique: Clearing phlegm faster
This study tests whether inhaling a saltwater spray before a special breathing exercise (ELTGOL) helps people with bronchiectasis cough up phlegm more easily. It's for adults who have daily phlegm, recent flare-ups, and have not smoked much.
GironaAges 18 years+ - NCT06801327Recruiting
Comparing two breathing therapies for bronchiectasis
This trial tests whether a new device called Simeox works better than standard chest physical therapy for people with bronchiectasis (widened airways that trap mucus). It compares how well each method clears mucus from the lungs.
Bologna, BolognaAges 18 years+ - NCT07566611Recruiting
Ciliary Function in Adults with Bronchiectasis
This study looks for signs of ciliary dyskinesia (a condition affecting tiny hair-like structures in the lungs) in adults who have bronchiectasis (damaged airways). Understanding this connection may help doctors better treat and manage your lung disease.
Indianapolis, IndianaAges 18 years+ - NCT07201051RecruitingPhase 2
Testing a new drug for people with bronchiectasis
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
Mobile, AlabamaAges 18–85 - NCT06368804RecruitingPhase 2
Comparing two antibiotics for early PA infection in bronchiectasis
This trial tests two different antibiotic treatments for adults with bronchiectasis who have a new or recent infection with Pseudomonas aeruginosa (PA) bacteria in their airways. The goal is to see which regimen works better to clear the infection early.
AmiensAges 18 years+ - NCT06760273Recruiting
Tobramycin for Pseudomonas infection in bronchiectasis
This study looks at the long-term effects of using an inhaled antibiotic called tobramycin to get rid of Pseudomonas aeruginosa bacteria in people with bronchiectasis. It may help keep the infection away and improve breathing health.
Hefei, AnhuiAges 18–80 - NCT04538859Recruiting
Study of causes of flare-ups and death in bronchiectasis
This study looks at what factors are linked to flare-ups and serious outcomes in people with non–cystic fibrosis bronchiectasis. You may be followed because your lung scans and recent stability help researchers understand what predicts worsening.
Hong Kong, Please SelectAges 18 years+ - NCT06631261Recruiting
Stepper test for lung and heart health in bronchiectasis
This study compares how the heart and lungs respond to a 6-minute stepper exercise in people with bronchiectasis versus healthy adults. It aims to better understand the physical impact of bronchiectasis on daily activities.
AnkaraAges 18 years+ - NCT07289100Recruiting
Smart home monitoring for lung flare-ups in CF and bronchiectasis
This trial tests if a smart home monitoring system (using sensors and AI) can detect sudden lung flare-ups early in people with cystic fibrosis or bronchiectasis. It may help you get treatment sooner when you are admitted to the hospital for IV antibiotics.
Cambridge, CambridgeshireAges 18 years+ - NCT06987214RecruitingPhase 1
Regenerative stem cell therapy for bronchiectasis
This trial tests whether transplanting your own lung stem cells can repair damaged airways caused by bronchiectasis. It is for people with moderate to severe breathing impairment and aims to improve lung function.
Qionghai, HainanAges 25–80 - NCT03791086Recruiting
BRIDGE study using health records and genetics for bronchiectasis
This study looks at how bronchiectasis (ongoing lung damage with mucus and infections) may happen by using your medical records and genetic information. It may help researchers find better ways to understand different bronchiectasis types and guide future treatments.
DundeeAges 18 years+ - NCT06900062Recruiting
Bronchiectasis Research Study at Shanghai Hospital
This study looks at the genes and health data of people with bronchiectasis to better understand the disease. It may help find new ways to treat or manage your condition.
Guiyang, GuizhouAges 18–85 - NCT07709494RecruitingPhase 1
Inhaled Rev-56 for healthy volunteers and people with bronchiectasis
This trial tests an inhaled drug called Rev-56 in healthy adults and in adults with non-cystic fibrosis bronchiectasis who have a chronic lung infection with Pseudomonas aeruginosa. It aims to see if the drug is safe, well-tolerated, and helps reduce the bacteria in the lungs.
Miami, FloridaAges 18–80 - NCT06820983Recruiting
Quality of life study for DDB with OPEP device
This study looks at how a breathing device called OPEP affects the quality of life of people with DDB (a lung condition that causes widening and damage to the airways). If you or your child has DDB and doesn't already use an OPEP device, this trial may help understand if starting one improves daily life.
AmiensAges 8 years+ - NCT07048262RecruitingPhase 2
Study of an inhaled drug for adults with non-CF bronchiectasis
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
QueenslandAges 18–85 - NCT07720375RecruitingPhase 2
Study of a new medication for adults with bronchiectasis
This study tests a new medication called Galvokimig to see if it helps reduce lung infections and improve quality of life in adults with bronchiectasis (a condition where lung airways are damaged and fill with mucus). It is a 24 to 52 week treatment, and you will be monitored closely for safety and effectiveness.
Plantation, FloridaAges 18–80 - NCT06326957Recruiting
Online program for chronic breathlessness
This trial tests an internet-based self-guided program to help adults with chronic breathlessness. It is designed for people who still feel short of breath despite treatment for conditions like COPD, lung disease, or cancer.
LondonAges 18–110
Hear when a new Bronchiectasis Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bronchiectasis adult?
- Yes. Clin2 currently lists 21 recruiting bronchiectasis adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bronchiectasis adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bronchiectasis adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.